Its important to know that most insurance companies do not cover peptide therapy
AHK-Cu significantly stimulates vascular endothelial growth factor (VEGF), a key driver of angiogenesis, or the formation of new capillaries that deliver oxygen and nutrients to dermal tissue
With estimates suggesting 20-50 million people could be using GLP-1 drugs, like Ozempic and Wegovy, by 2030, some big brands are already aligning their products to meet this new audience's needs
The dermis and subcutis are the most common locations, but the epidermis can also be involved in conditions such as Pagetoid breast cancer
Researchers have also been exploring carbetocin, an oxytocin analogue, for potential effects on hyperphagia and social cognition
Rahman, N., Buck, J., & Levin, L